Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial

Nav

General Info

Geography

Fiji (FJI)

Time period covered

01/2021 - 12/2021

Data type

Scientific literature

Keywords

Lymphatic filariasis

Citation

Authors

Hardy M, Samuela J, Kama M, Tuicakau M, Romani L, Whitfeld MJ, King CL, Weil GJ, Grobler AC, Robinson LJ, Kaldor JM, Steer AC

Journal

Clin Infect Dis

Volume

Issue

Pages

994-1002

Publication year

2021

Suggested citation

Hardy M, Samuela J, Kama M, Tuicakau M, Romani L, Whitfeld MJ, King CL, Weil GJ, Grobler AC, Robinson LJ, Kaldor JM, Steer AC. Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial. Clin Infect Dis. 2021; 73(6): 994-1002.

DOI

10.1093/cid/ciab202

PMID

33728462

GHDx Entry last modified on: Mar 14, 2022

Header sites

Search form

Main menu

Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial

Nav